Please login to the form below

Not currently logged in
Email:
Password:

Purdue Pharma appoints Dr Alan Dunton

He joins the pain specialist as senior VP of research and development

Purdue Pharma Dr Alan DuntonPurdue Pharma has appointed Dr Alan Dunton as senior vice president of research and development in a role that also sees him join its executive committee.

Dr Dunton will serve as the company's lead scientist and oversee medical research, drug safety, clinical pharmacology, virtual discovery, project management, and pharmaceutics and analytics teams.

He will report to chief executive officer Mark Timney who said: "At a time of transformation for Purdue, Alan brings the right skills and

experience to diversify and grow our portfolio."

Dr Dunton has spent 33 years in the industry discovering and developing new prescription and over-the-counter products. In 2006, he

founded Danerius, a biotechnology and pharmaceutical consulting business, which he led until joining Purdue. 

Prior to starting Danerius, Dr. Dunton held executive-level positions in the pharmaceutical and biotechnology industries, including President and Chief Executive Officer of Panacos Pharmaceuticals and Metaphore Pharmaceuticals.

He was also the president and managing director of the Janssen Research Foundation, the R&D arm of the pharmaceuticals division at Johnson & Johnson.

7th December 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy
MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget....
Innovative approaches in the treatment of multiple sclerosis
Blue Latitude Health Senior Associate Consultant Will Frostick delves into the MS treatment landscape and explores some of the cutting-edge treatments on the horizon....
Mobilising the public to combat the antimicrobial resistance crisis
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines...

Infographics